Replies to post #110586 on Amarantus Bioscience Holdings Inc (AMBS)

[GS1]

ESS acquisition is the real deal which most have overlooked...Once this trial starts and investors will notice how big is this.

ACAD is trading $30 per share on one drug that is yet to be approved by FDA.